Source: Eur Respir Monogr 2019; 84: 1-15
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
William W. Busse. Definition and impact of severe asthma. Eur Respir Monogr 2019; 84: 1-15

Member's Comments

No comment yet.

Related content which might interest you: Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Exacerbations in severe persistent asthma - impact of risk factors control Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Improved definition of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Assessment of severe asthma Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 Pathophysiology of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007